Group 1 - The core viewpoint of the report indicates that Nike's management has provided a guidance for a low single-digit decline in sales for the third fiscal quarter, which is seen as slightly negative for ODM suppliers like Shenzhou International [1] - Despite the cautious outlook from Nike, Shenzhou is expected to gain more market share in new product areas such as running, golf, and basketball jerseys this year [1] - Shenzhou's management has also given a conservative forecast, expecting mid-single-digit sales growth in the second half of 2025, which is lower than previous high single-digit predictions, reflecting the impact of Nike's latest outlook [1] Group 2 - Citi predicts that Nike's sales orders for Shenzhou will remain flat rather than decline in 2026, and with visibility on orders from the top four clients, Shenzhou's sales are expected to achieve high single-digit growth in 2026 [1] - The report suggests that if Shenzhou's stock price experiences a pullback due to Nike's cautious outlook, it may present a buying opportunity, maintaining a "buy" rating for Shenzhou with a target price of HKD 94 [1]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14% [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% on its debut, and Xidi Zhijia (03881), which fell over 8% [1] - The U.S. Senate passed a revised version of the Biosecurity Act as part of the National Defense Authorization Act for fiscal year 2026, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceuticals-B (02142) saw a nearly 7% increase after signing a business development deal worth over $1 billion with Bristol-Myers Squibb [2] - China Duty Free Group (01880) rebounded nearly 7% after winning bids for two major airport duty-free projects in Shanghai, with market attention on the results of the capital airport bidding [3] - Youjia Innovation (02431) rose over 12% as the large-scale rollout of L3 technology approaches, with the company having preemptively positioned itself for L2 and L4 technologies [4] Group 3 - Nine Dragons Paper (02689) increased by over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [5] - Southern Manganese (01091) rose over 9% due to multiple factors driving the continuous increase in electrolytic manganese prices [6] - Yangtze Optical Fibre and Cable (06869) surged over 10%, with a cumulative increase of over 30% in the past three days, driven by sustained demand for optical fibres and cables from AI [7] Group 4 - Ganwan (09890) increased by over 5% after issuing zero-coupon convertible bonds at a premium, raising HKD 450 million to enhance its "AI + gaming" initiatives [8] - Liqin Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [9] - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [10]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14%. The morning trading volume reached 97.5 billion HKD [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% upon debut, and Xidi Zhijia (03881), which fell over 8% after its listing [1] - The U.S. Senate passed a revised version of the Biodefense Act as part of the National Defense Authorization Act for fiscal year 2026, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceuticals-B (02142) saw a nearly 7% increase after signing a business development deal worth over 1 billion USD with Bristol-Myers Squibb [2] - China Duty Free Group (601888) (01880) rebounded nearly 7% after winning bids for two major duty-free projects at Shanghai airports, with market attention on the results of the Capital Airport tender [2] - Youjia Innovation (02431) surged over 12% as L3 large-scale deployment approaches, with the company having made forward-looking arrangements for L2+ and L4 [2] - Nine Dragons Paper (02689) rose over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [2] Group 3 - South Manganese (01091) increased by over 9% due to multiple factors driving the continuous rise in electrolytic manganese prices [3] Group 4 - Yangtze Optical Fibre (601869) (06869) rose over 10%, with a cumulative increase of over 30% in the past three days, driven by sustained demand for optical fibers and cables from AI [4] Group 5 - Ganwan (09890) increased by over 5% after issuing zero-coupon convertible bonds at a premium, raising 450 million HKD to enhance its "AI + gaming" strategy [5] Group 6 - Liqin Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [6] Group 7 - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [7]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14% [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% on its debut, and Xidi Zhijia (03881), which fell over 8% [1] - The U.S. Senate passed a revised version of the Biological Safety Act as part of the 2026 National Defense Authorization Act, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceutical-B (02142) saw a nearly 7% increase after signing a BD deal worth over $1 billion with Bristol-Myers Squibb [2] - China Duty Free Group (01880) rebounded nearly 7% after winning bids for duty-free projects at two major airports in Shanghai, with market attention on the results of the capital airport bidding [3] Group 3 - Youjia Innovation (02431) rose over 12% as L3 large-scale deployment approaches, with the company strategically positioning itself for L2+L4 technologies [4] - Nine Dragons Paper (02689) increased over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [4] Group 4 - Southern Manganese (01091) rose over 9% due to multiple factors driving the continuous increase in electrolytic manganese prices [5] - Changfei Optical Fiber and Cable (06869) surged over 10%, with a cumulative increase of over 30% in the past three days, driven by AI demand for optical fiber and cable [6] - Ganwan (09890) increased over 5% after issuing zero-coupon convertible bonds at a premium, raising HKD 450 million to enhance its "AI + gaming" strategy [7] - Likun Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [8] - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [9]

Market Performance - The Hang Seng Index increased by 0.65% and the Hang Seng Tech Index rose by 1.14% [1] - The Hong Kong Tech ETF (159751) gained 1.76%, while the Hang Seng Hong Kong Stock Connect ETF (159318) increased by 1.02% [1] Sector Performance - The life sciences tools and automotive parts sectors showed the highest gains [1] - The media, forestry, and paper products sectors experienced the largest declines [1] Individual Stock Movements - Zhihui Mining surged over 111% [1] - China Duty Free Group rose by 7.56%, Horizon Robotics (W) increased by 7.16%, WuXi Biologics gained 6.48%, and Xpeng Motors (W) was up by 5.69% [1] - Shenzhou International fell by 3.89% and China National Heavy Duty Truck Group dropped by 5.71% [1] - Youjia Innovation increased by 12.13% and CIMC (China International Marine Containers) rose by 11.96% [1]

Group 1 - Shenzhou International (02313.HK) experienced a decline of over 3%, specifically a drop of 3.02%, bringing its share price to HKD 61.05 [2] - The trading volume for Shenzhou International reached HKD 123 million [2]

Group 1 - The core point of the article is that Shenzhou International (02313) experienced a decline of over 3% in its stock price, attributed to the poor financial performance of its major client, Nike, which reported a 32% year-on-year drop in net profit for Q2 of fiscal year 2026 [1][1][1] - Nike's net profit fell from $1.16 billion in the same period last year to $792 million, despite revenue and earnings exceeding market expectations [1][1][1] - Revenue in Greater China for Nike decreased by 17% to $1.7 billion, with EBITDA dropping significantly by 49% [1][1][1] Group 2 - Citigroup recently downgraded its earnings forecast for Shenzhou International for 2025 to 2027 by 2%, lowering the target price from HKD 95 to HKD 94 while maintaining a "buy" rating [1][1][1] - The decline in Shenzhou's stock price may reflect management's conservative outlook on sales, which could present a buying opportunity, as the expected dividend yield for fiscal year 2026 is 4.8% and the projected compound annual growth rate for earnings per share over the next three years is 12% [1][1][1]

Core Viewpoint - Shenzhou International (02313) experienced a decline of over 3%, currently trading at HKD 61.05, with a transaction volume of HKD 123 million. This drop is linked to Nike's disappointing Q2 FY2026 earnings report, which led to a more than 10% drop in Nike's stock price [1] Group 1: Financial Performance - Nike's Q2 FY2026 report showed that despite revenue and profit exceeding market expectations, net profit fell by 32% year-on-year, dropping from USD 1.16 billion to USD 792 million [1] - Revenue in Greater China for Nike decreased by 17% year-on-year to USD 1.7 billion, with EBITDA declining significantly by 49% [1] Group 2: Analyst Insights - Citigroup recently revised its earnings forecast for Shenzhou International for 2025 to 2027 down by 2%, lowering the target price from HKD 95 to HKD 94 while maintaining a "Buy" rating [1] - The decline in Shenzhou International's stock price may reflect management's conservative outlook on sales, which could present a buying opportunity, as the expected dividend yield for FY2026 is 4.8% and the projected annual compound growth rate for earnings per share over the next three years is 12% [1]

Group 1 - The core point of the news is that southbound funds have increased their holdings in Shenzhou International (02313.HK) by 1.57 million shares on December 18, 2025, marking a total net increase of 4.87 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have increased their holdings in Shenzhou International on 13 occasions, resulting in a cumulative net increase of 3.91 million shares [1] - As of now, southbound funds hold 10.4 million shares of Shenzhou International, which represents 6.91% of the company's total issued ordinary shares [1] Group 2 - The total number of shares held by southbound funds on December 18, 2025, is 10.4 million, with a change of 1.53% from the previous day [2] - The shareholding changes over the last five trading days show a consistent increase, with the highest increase of 1.53% recorded on December 18, 2025 [2] - Shenzhou International Group Holdings Limited primarily engages in the production and sale of knitted apparel products, operating through a combination of OEM and ODM manufacturing for clients [2]

Group 1 - The Hong Kong stock market has stabilized, maintaining a narrow range around the mid-axis during the morning session, with slight gains in consumer and technology sectors, while the internet and healthcare sectors experienced a downturn [1] - The consumer sector showed signs of recovery, with a slight increase of 0.32% by midday, driven by stocks such as Li Ning up 4.37%, Shenzhou International up 2.26%, and several others like Stone Pharmaceutical, Lao Pu Gold, WuXi Biologics, and Pop Mart all rising over 1% [3] - The technology sector also saw a minor increase of 0.14% by midday, with Meituan up 1.21%, while major players like JD Group, Alibaba, Tencent Holdings, and SMIC posted slight gains; however, BYD and NetEase faced minor declines [3] Group 2 - The healthcare sector had a lackluster performance, with Stone Pharmaceutical up 1.9% and WuXi Biologics up 1.68%, while other stocks like BeiGene, Innovent Biologics, and 3SBio saw slight increases; in contrast, companies like CanSino Biologics, China Biologic Products, JD Health, and Hansoh Pharmaceutical experienced minor declines [3]